6533b825fe1ef96bd1282fad

RESEARCH PRODUCT

Advances in immunotherapy of castration-resistant prostate cancer: Bisphosphonates, phosphoantigens and more.

Francesco DieliN. CaccamoS. Meraviglia

subject

Settore MED/04 - Patologia Generaleprostate cancer bisphosphonates gamma delta T cellshttp://hdl.handle.net/10447/37577